https://www.selleckchem.com/pr....oducts/nvp-bgt226.ht
9-16.9 billion) in discounted, lifetime direct medical costs (2019 US dollars). Most of this cost was due to sexually acquired HIV ($13.7 billion) and HPV ($0.8 billion). STIs in women accounted for about one fourth of the cost of incident STIs when including HIV, but about three fourths when excluding HIV. STIs among 15- to 24-year-olds accounted for $4.2 billion (26%) of the cost of incident STIs. Incident STIs continue to impose a considerable lifetime medical cost burden in the United States. These results can inform health econo